| 000 | 01808 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516172240.0 | ||
| 264 | 0 | _c20140402 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1806-4841 | ||
| 024 | 7 |
_a10.1590/abd1806-4841.20132035 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMelgaço, Sarah Suyanne Carvalho | |
| 245 | 0 | 0 |
_aEvaluation of renal function in patients with psoriasis using immunobiologicals. _h[electronic resource] |
| 260 |
_bAnais brasileiros de dermatologia _c |
||
| 300 |
_a667-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAlbuminuria |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
| 650 | 0 | 4 |
_aBiological Products _xadverse effects |
| 650 | 0 | 4 |
_aCreatinine _xurine |
| 650 | 0 | 4 |
_aDermatologic Agents _xadverse effects |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xadverse effects |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 |
_aKidney _xphysiopathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aSilva, Geraldo Bezerra da | |
| 700 | 1 | _aDantas, Amanda Maria Menezes | |
| 700 | 1 | _aVasconcelos, Ana Mirella Arcanjo | |
| 700 | 1 | _aSiqueira, Verônica Riquet de | |
| 700 | 1 | _aVieira, Ana Patrícia Freitas | |
| 700 | 1 | _aDaher, Elizabeth de Francesco | |
| 773 | 0 |
_tAnais brasileiros de dermatologia _gvol. 88 _gno. 4 _gp. 667-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1590/abd1806-4841.20132035 _zAvailable from publisher's website |
| 999 |
_c23118950 _d23118950 |
||